eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
the report "correctly points out that there really was no playbook for dealing with what was an unprecedented health crisis," san diego mayor kevin faulconer said.
.
senator: sir, i have the numbers in front of me. how can you keep this secret from the public?
.
.
.
. © 2018 abc news internet ventures. all rights reserved.
.